Pure Global

SARS-CoV-2/influenza A/B nucleic acid IVD, kit, nucleic acid technique (NAT) - UK MHRA Medical Device Registration

SARS-CoV-2/influenza A/B nucleic acid IVD, kit, nucleic acid technique (NAT) is a medical device registered with the UK's Medicines and Healthcare products Regulatory Agency (MHRA) under Device ID 134500. The device is manufactured by Kangmei Tianhong Biotech (Beijing) Co., Ltd. from China, classified as In Vitro Diagnostic Device. The authorized representative in the UK is Wellkang Ltd.

This page provides comprehensive regulatory information including complete registration details, manufacturer information, device classification, authorized representative details, and related products. Pure Global AI offers free access to 150,962+ UK MHRA medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
MHRA Registered
In Vitro Diagnostic Device
๐Ÿ‡ฌ๐Ÿ‡ง
SARS-CoV-2/influenza A/B nucleic acid IVD, kit, nucleic acid technique (NAT)
MHRA Device ID: 134500โ€ขRef: 134500

Device Type

In Vitro Diagnostic Device

Devices

SARS-CoV-2/influenza A/B nucleic acid IVD, kit, nucleic acid technique (NAT)

Type

IVD General

Date Registered

Nov 26, 2024

Last Updated

Oct 17, 2023

Manufacturer Information

Address

#16, No.1 Gaolizhang Road,

Haidian, Beijing, China

Created Date

Dec 16, 2021

Authorized Representative

Relationship Type

Authorised Representative (Northern Ireland)

Address

Enterprise Hub, NW Business Complex 1 Beraghmore Road

Derry, Northern Ireland, Northern Ireland, United Kingdom

Postcode: BT48 8SE

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing